Cancel
Stephanie Tagliatela
Co-founder, Chief Scientific Officer & Board Member
@
Encoded Therapeutics
About Stephanie Tagliatela
Stephanie Tagliatela is a co-founder, Chief Scientific Officer, and Board Member, recognized as one of the top 30 biotech leaders under 40 by Business Insider for her contributions to the field.
Known information
Stephanie Tagliatela, with a solid foundation in biological sciences from Mount Holyoke College and advanced expertise from her doctoral research in Molecular and Cellular Neuroscience at MIT, has established herself as a prominent figure in biotechnology. As a co-founder, Chief Scientific Officer, and Board Member, she has been instrumental in pioneering research and development in the biotech industry. Her work has earned her a spot on Business Insider’s list of the 30 biotech leaders under 40, highlighting her role in searching for breakthrough treatments and shaping the future of medicine.
About Encoded Therapeutics
Encoded Therapeutics focuses on developing precision gene therapies for pediatric central nervous system disorders, with its leading program, ETX101, targeting Dravet syndrome.
Report inaccurate information
